KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Hologic (HOLX) Short-term Investments (2017 - 2025)

Hologic's Short-term Investments history spans 3 years, with the latest figure at $196.7 million for Q4 2025.

For Q4 2025, Short-term Investments rose 3.2% year-over-year to $196.7 million; the TTM value through Dec 2025 reached $196.7 million, up 3.2%, while the annual FY2025 figure was $243.2 million, 40.25% up from the prior year.
Short-term Investments for Q4 2025 was $196.7 million at Hologic, down from $243.2 million in the prior quarter.
Across five years, Short-term Investments topped out at $243.2 million in Q3 2025 and bottomed at $143.9 million in Q2 2025.